Literature DB >> 15162593

Acute bronchitis: state of the art diagnosis and therapy.

Fernando J Martinez1.   

Abstract

In managing acute bronchitis, pneumonia or an exacerbation of underlying chronic bronchitis should be excluded. Simple bronchitis is best treated symptomatically while an exacerbation of chronic bronchitis can be treated with antibiotics. Broad spectrum antibiotics are appropriate in selected patients.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15162593      PMCID： PMC7091331          DOI： 10.1007/s12019-004-0025-z

Source DB:  PubMed          Journal:  Compr Ther        ISSN： 0098-8243


  158 in total

1.  Predictors of antibiotic prescribing for nonspecific upper respiratory infections, acute bronchitis, and acute sinusitis. An UPRNet study. Upper Peninsula Research Network.

Authors:  S A Dosh; J M Hickner; A G Mainous; M H Ebell
Journal:  J Fam Pract       Date:  2000-05       Impact factor: 0.493

Review 2.  Respiratory tract infections: when is antibiotic therapy indicated?

Authors:  H Lode
Journal:  Clin Ther       Date:  1991 Jan-Feb       Impact factor: 3.393

Review 3.  A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new respiratory quinolones'.

Authors:  J M Blondeau
Journal:  J Antimicrob Chemother       Date:  1999-05       Impact factor: 5.790

Review 4.  Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review.

Authors:  J M Singh; V A Palda; M B Stanbrook; K R Chapman
Journal:  Arch Intern Med       Date:  2002 Dec 9-23

5.  Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination.

Authors:  J P Metlay; W N Kapoor; M J Fine
Journal:  JAMA       Date:  1997-11-05       Impact factor: 56.272

6.  Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group.

Authors:  A Anzueto; M S Niederman; G S Tillotson
Journal:  Clin Ther       Date:  1998 Sep-Oct       Impact factor: 3.393

7.  Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation.

Authors:  R Pela; F Marchesani; C Agostinelli; D Staccioli; L Cecarini; C Bassotti; C M Sanguinetti
Journal:  Monaldi Arch Chest Dis       Date:  1998-06

8.  Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.

Authors:  G Rohde; A Wiethege; I Borg; M Kauth; T T Bauer; A Gillissen; A Bufe; G Schultze-Werninghaus
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

9.  Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions.

Authors:  L Kaiser; D Lew; B Hirschel; R Auckenthaler; A Morabia; A Heald; P Benedict; F Terrier; W Wunderli; L Matter; D Germann; J Voegeli; H Stalder
Journal:  Lancet       Date:  1996-06-01       Impact factor: 79.321

Review 10.  Exacerbations: etiology and pathophysiologic mechanisms.

Authors:  Jadwiga A Wedzicha
Journal:  Chest       Date:  2002-05       Impact factor: 9.410
View more
  3 in total

Review 1.  Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez
Journal:  Proc Am Thorac Soc       Date:  2007-12

2.  Assessment of the Efficacy and Safety of Ivy Leaf (Hedera helix) Cough Syrup Compared with Acetylcysteine in Adults and Children with Acute Bronchitis.

Authors:  Esther Kruttschnitt; Tankred Wegener; Catherine Zahner; Silke Henzen-Bücking
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-04       Impact factor: 2.629

Review 3.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.